Published 1989 | Version v1
Book

Gd-DTPA-bismorpholide

Description

The aim of this study is to characterize MR enhancement properties of a new low-osmolarity MR imaging contrast agent, Gd-DTPA-bismorpholide (gadopenamide) having an extracellular fluid space distribution. Compared with Gd- DTPA dimeglumine, gadopenamide is lower in osmolality (810 vs 1,900 mOsm/kg), higher in acute mouse tolerance (LD50, 30 vs 6 mmol/kg), without significant differences in relaxivity, viscosity, biodistribution, or in vivo stability. Animal experiments were performed with use of a 2.0-T CSI unit with a spin-echo sequence (TR 310 msec/TE 15 msec) in normal rats, in tumor-bearing mice, and in rat models of myocardial ischemia and middle cerebral artery occlusion

Additional details

Additional titles

Subtitle (English)
A new low-osmolar contrast agent for MR imaging

Publishing Information

Publisher
Radiological Society of North America Inc.
Imprint Place
Oak Brook, IL (USA)
Imprint Title
Proceedings of the 75th anniversary scientific assembly and annual meeting Radiological Society of North America (Abstracts)
Imprint Pagination
654 p.
Journal Page Range
p. 409.

Conference

Title
75. anniversary scientific assembly and annual meeting of the Radiological Society of North America.
Dates
26 Nov - 1 Dec 1989.
Place
Chicago, IL (USA).

Optional Information

Secondary number(s)
CONF-8911163--.